Cure For The Common Cold Coming?


Looks like they’re on the right path:

Australian drug maker Biota Wednesday reported the stunning success of its antiviral compound, named Vapendavir.

Tested in 300 asthmatic patients infected with the cold-causing human rhinovirus, the clinical trial showed that cold symptoms eased quickly and the duration of the infection was shortened considerably.

Patients given a placebo experienced the worst cold symptoms at 2.5 days, whereas those dosed with Vapendavir began rapid recovery after just 1.7 days.

That sounds like a good thing, but it’s still a long way from appearing on your local store shelves.

I guess for the moment I’ll stick with over-the-counter remedies.

Advertisements

Tags: , ,

About Conservative Wanderer

Conservative Wanderer is currently Editor-in-Chief of That's Freedom You Hear! That means anything that goes wrong can be blamed on him. Previously he was a contributor to the PJ Tatler.
%d bloggers like this: